Skip to main content

Current Treatment Options in Gastroenterology OnlineFirst articles

13.05.2024

Obesity and Esophageal Dysfunction

Obesity is now the most common chronic disease in the world, with more than 1 billion people affected worldwide [ 1 ]. It is projected that by 2030, 1 in 2 persons will meet criteria for obesity and 1 in 4 persons for severe obesity in the United …

verfasst von:
Khushboo Gala, MBBS, Karthik Ravi, MD

08.05.2024

Current Trends and Developments in Radiologic Assessment of Chronic Pancreatitis

Radiological assessment of the pancreas in chronic pancreatitis (CP) has become increasingly important in recent years. This is driven by an increased clinical focus on improving CP diagnosis and grading, advancing clinical research focused on …

verfasst von:
Surenth Nalliah, MD, Esben Bolvig Mark, MSc, PhD, Søren Schou Olesen, MD, PhD, Tine Maria Hansen, MSc, PhD, Jens Brøndum Frøkjær, MD, PhD

26.04.2024

Pancreatic Cyst Fluid Assessment: Updates in Genetic Analysis and Risk for Progression

The prevalence of pancreatic cysts has been cited to be as high as 2.5% of the general population, with up to 40% of individuals aged 70 or older having at least one pancreatic cyst ( 1 , 2 ). Pancreatic cysts are of relevance to both patient and …

verfasst von:
Muaz Aijazi, MD, Rohit Das, MD

17.04.2024

Robotic Surgeries in Benign and Malignant Pancreatic Disease

The term “pancreatectomy” encompasses the surgical removal of either a portion or the entirety of the pancreas, with or without adjacent organs. This intricate surgical procedure carries a notable risk profile, including surgery-related morbidity …

verfasst von:
Asmita Chopra, MD, Jiage Qian, MSPH, Adam Tcharni, BA, Alessandro Paniccia, MD

03.04.2024

Tools for Bedsite Pain Assessments in Chronic Pancreatitis

Chronic pancreatitis (CP) is a complex and debilitating condition characterized by progressive inflammation in the pancreatic gland. The most common complication is pain, affecting 60–80% of patients [ 1 ]. Pain significantly affects the quality of …

verfasst von:
Louise Kuhlmann, MD, PhD, Asbjørn Mohr Drewes, MD, PhD, DMSc

27.03.2024

FLIP in Clinical Practice: When Is It Helpful?

Esophageal dysmotility is a common cause of gastrointestinal symptoms, including dysphagia and symptoms associated with gastroesophageal reflux [ 1 , 2 ] It is not only the hallmark of primary esophageal disorders like achalasia, but also of …

verfasst von:
Elena C. Pezzino, MD, Daniel R. Arndorfer, MD, Dustin A. Carlson, MD, MSCI

Open Access 23.03.2024 | Correction

Correction to: Therapy of Upper Gastrointestinal Symptoms: Experience with a Medical Device Made of Natural Substances

verfasst von:
Enrico Stefano Corazziari, MD, Emanuela Ribichini, MD, PhD

15.03.2024

The Diagnostic Approach of Benign Esophageal Tumors: A Narrative Review

Benign esophageal tumors (BETs) are rare clinical entities with a reported incidence of less than 1%. However, the frequency appears to be rising, which is likely driven by an increase in their incidental detection [ 1 ]. Indeed, most BETs do not …

verfasst von:
Alex R. Jones, MD, Preksha Vankawala, MD, Tarek Sawas, MD, MPH

12.03.2024

Barrett’s Esophagus: Who and How Do We Screen?

Barrett’s esophagus (BE) is characterized by intestinal metaplasia (IM) of the distal esophagus, specifically the replacement of squamous epithelium by specialized intestinal columnar epithelium [ 1 ]. The metaplasia is thought to be in response to …

verfasst von:
Bibek Saha, MD, Anjul Verma, MBBS, Prasad G. Iyer, MD, MS

Open Access 14.04.2023

Innovations in the Treatment of Gastric Outlet Obstruction: Is This the Era of Endoscopic Ultrasonography-Guided Gastroenterostomy?

Gastric outlet obstruction (GOO) is a phenomenon that is characterized by mechanical obstruction of the distal stomach, pylorus, or duodenum [ 1 ]. The condition is caused by several benign and malignant diseases. Peptic ulcer disease due to …

verfasst von:
Yorick L. van de Pavert, MD, MA, Leon M. G. Moons, MD, PhD, Auke Bogte, MD, PhD, Frank P. Vleggaar, MD, PhD

30.11.2019 | Obesity and Nutrition (O Pickett-Blakely, Section Editor)

Beyond the Calories—Is the Problem in the Processing?

Obesity is defined by the Obesity Medicine Association as a chronic, relapsing, multi-factorial, neurobehavioral disease that promotes adipose tissue dysfunction and abnormal fat mass physical forces that results in adverse metabolic, biochemical …

verfasst von:
Janese Laster, MD, Leigh A. Frame, PhD, MHS

25.11.2019 | Genetics in Gastroenterology Practice (B Katona, Section Editor)

Genetic testing for hereditary gastrointestinal cancer syndromes: Interpreting results in today's practice

Over the last several decades, advances in genomics have led to the discovery of multiple predisposition genes linked to increased risk for gastrointestinal (GI) cancer [ 1 ]. While several predisposition syndromes are well-characterized with …

verfasst von:
Jacquelyn M. Powers, MS LCGC, Jessica E. Ebrahimzadeh, MS LCGC, Bryson W. Katona, MD PhD

15.11.2019 | Stomach (P Malfertheiner, Section Editor)

What is the Relevance of Gastric Microbiota Beyond H. pylori?

The discovery of Helicobacter pylori ( H. pylori ) more than 35 years ago signed a turning point in our understanding of gastroduodenal pathologies. While chronic active gastritis is initiated in all subjects infected with H. pylori and in its …

verfasst von:
Kerstin Schütte, MD, Peter Malfertheiner, MD, Christian Schulz, MD

31.10.2019 | Nutrition and Obesity (O Pickett-Blakely, Section Editor)

Nutrition in Chronic Liver Disease

Malnutrition in chronic advanced liver disease (CLD) occurs in 20–50% of patients [ 1 •] reaching close to 80% in patients with alcoholic liver disease (ALD) [ 2 ]. Cirrhotic patients, especially those with a body mass index (BMI) of < 18.5 kg/m 2 …

verfasst von:
Yala Kirthi Reddy, Benedict Maliakkal, Uchenna Agbim